Increased Thromboxane A<sub>2</sub> Levels in Pulmonary Artery Smooth Muscle Cells Isolated from Patients with Chronic Obstructive Pulmonary Disease
<i>Introduction:</i> Pulmonary hypertension due to chronic obstructive pulmonary disease (COPD) is classified as Group 3 pulmonary hypertension, with no current proven targeted therapies. It has been shown that cigarette smoke, the main risk factor for COPD, can increase thromboxane A<...
Main Author: | Abdullah A. Alqarni |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-01-01
|
Series: | Medicina |
Subjects: | |
Online Access: | https://www.mdpi.com/1648-9144/59/1/165 |
Similar Items
-
NTP42, a novel antagonist of the thromboxane receptor, attenuates experimentally induced pulmonary arterial hypertension
by: Eamon P. Mulvaney, et al.
Published: (2020-04-01) -
Nitric oxide augments signaling for contraction in hypoxic pulmonary arterial smooth muscle—Implications for hypoxic pulmonary hypertension
by: Martha Hinton, et al.
Published: (2023-03-01) -
Downregulation of Soluble Guanylate Cyclase and Protein Kinase G With Upregulated ROCK2 in the Pulmonary Artery Leads to Thromboxane A2 Sensitization in Monocrotaline-Induced Pulmonary Hypertensive Rats
by: Suhan Cho, et al.
Published: (2021-02-01) -
The Role and Regulation of Thromboxane A<sub>2</sub> Signaling in Cancer-Trojan Horses and Misdirection
by: Anthony W. Ashton, et al.
Published: (2022-09-01) -
Integrative Proteomic and Phosphoproteomic Analyses of Hypoxia-Treated Pulmonary Artery Smooth Muscle Cells
by: Ang Luo, et al.
Published: (2022-06-01)